AI Generated Image
Medical Journal Retracts Study Claiming Cancer Therapy Is More Effective When Given in the Morning
The New York Times • • general
Key Points:
- A clinical trial published in February in Nature Medicine suggested that administering immunotherapy for lung cancer patients in the morning doubled the duration cancer was kept at bay and nearly doubled patient survival compared to afternoon infusions.
- The study generated significant interest among patients and oncologists, leading to numerous inquiries about switching to morning treatment sessions.
- Nature Medicine retracted the study due to multiple inconsistencies and irregularities, including changes to locked records during the trial, discrepancies between study plans, unusual patient retention with no dropouts, and irregular timing of follow-up scans.
- Experts involved in the post-publication review described the findings as "too good to be true," raising concerns about the study’s validity and reliability.
